Equities Analysts Offer Predictions for THC Q1 Earnings

Tenet Healthcare Co. (NYSE:THC) – Equities researchers at Zacks Research cut their Q1 2026 earnings per share (EPS) estimates for Tenet Healthcare in a report released on Wednesday, March 26th. Zacks Research analyst R. Department now forecasts that the company will post earnings of $3.43 per share for the quarter, down from their prior forecast of $3.45. The consensus estimate for Tenet Healthcare’s current full-year earnings is $12.24 per share. Zacks Research also issued estimates for Tenet Healthcare’s Q4 2026 earnings at $3.56 EPS and FY2026 earnings at $13.40 EPS.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings data on Wednesday, February 12th. The company reported $3.44 EPS for the quarter, beating analysts’ consensus estimates of $2.95 by $0.49. Tenet Healthcare had a return on equity of 21.88% and a net margin of 15.48%.

THC has been the subject of a number of other reports. StockNews.com upgraded shares of Tenet Healthcare from a “hold” rating to a “buy” rating in a research report on Thursday, March 13th. Cantor Fitzgerald reissued an “overweight” rating and set a $177.00 target price on shares of Tenet Healthcare in a report on Thursday, February 13th. Morgan Stanley started coverage on Tenet Healthcare in a research note on Wednesday. They issued an “overweight” rating and a $165.00 price target for the company. KeyCorp decreased their target price on shares of Tenet Healthcare from $200.00 to $185.00 and set an “overweight” rating on the stock in a report on Tuesday, January 7th. Finally, The Goldman Sachs Group downgraded shares of Tenet Healthcare from a “buy” rating to a “neutral” rating and cut their price target for the stock from $196.00 to $140.00 in a report on Monday, December 16th. Three investment analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $166.41.

Tenet Healthcare Price Performance

Shares of Tenet Healthcare stock opened at $134.41 on Friday. The company has a 50-day simple moving average of $132.38 and a two-hundred day simple moving average of $142.64. Tenet Healthcare has a twelve month low of $90.03 and a twelve month high of $171.20. The stock has a market capitalization of $12.79 billion, a price-to-earnings ratio of 4.17, a price-to-earnings-growth ratio of 1.02 and a beta of 2.06. The company has a quick ratio of 1.70, a current ratio of 1.78 and a debt-to-equity ratio of 2.25.

Insider Buying and Selling

In related news, Director J Robert Kerrey sold 9,525 shares of the firm’s stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $125.43, for a total transaction of $1,194,720.75. Following the completion of the transaction, the director now directly owns 27,378 shares of the company’s stock, valued at $3,434,022.54. This trade represents a 25.81 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 0.93% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Tenet Healthcare

A number of hedge funds have recently made changes to their positions in THC. Wealth Enhancement Advisory Services LLC increased its position in Tenet Healthcare by 10.3% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 8,836 shares of the company’s stock valued at $1,115,000 after purchasing an additional 827 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in shares of Tenet Healthcare during the fourth quarter worth $8,783,000. Forum Financial Management LP raised its stake in Tenet Healthcare by 43.5% during the fourth quarter. Forum Financial Management LP now owns 2,469 shares of the company’s stock worth $312,000 after buying an additional 749 shares during the last quarter. Neo Ivy Capital Management bought a new stake in Tenet Healthcare during the fourth quarter valued at $2,773,000. Finally, Vise Technologies Inc. raised its position in shares of Tenet Healthcare by 28.4% in the 4th quarter. Vise Technologies Inc. now owns 1,613 shares of the company’s stock worth $204,000 after acquiring an additional 357 shares in the last quarter. 95.44% of the stock is currently owned by institutional investors.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.